Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy
=========================================================================================================================================================================================================

* Koji Nagaoka
* Masataka Shirai
* Kiyomi Taniguchi
* Akihiro Hosoi
* Changbo Sun
* Yukari Kobayashi
* Kazuhiro Maejima
* Masashi Fujita
* Hidewaki Nakagawa
* Sachiyo Nomura
* Kazuhiro Kakimi